Arne Engelsberg

1.6k citations
16 papers · 600 indexed · h-index 10
Topics
Prostate Cancer Treatment and Research (4 papers)PARP inhibition in cancer therapy (4 papers)Polyomavirus and related diseases (3 papers)

In The Last Decade

Arne Engelsberg

15 papers receiving 593 citations

Peers

Arne Engelsberg
Comparison fields: 5 of 64
  • Molecular Biology 274
  • Immunology 271
  • Oncology 251
  • Pulmonary and Respiratory Medicine 85
  • Epidemiology 78
Replace Semjon Willier with:
Semjon Willier Germany
Patrick Fernandes Rodrigues United States
A Haimovici Germany
Anupama Pasam Australia
Lucio Gómez Spain
Xinyi Tu United States
Laurie Graham United States
Kanstantsin V. Katlinski United States
Bas van der Woning Belgium
Mark L. Sandberg United States
Arne Engelsberg relative to Semjon Willier Germany Semjon Willier's profile →
Citations per field
00.5×2.8×
Semjon Willier · 1×
Citations per year

Countries citing papers authored by Arne Engelsberg

Since Specialization
Citations

This map shows the geographic impact of Arne Engelsberg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Arne Engelsberg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Arne Engelsberg more than expected).

Fields of papers citing papers by Arne Engelsberg

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Arne Engelsberg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Arne Engelsberg. The network helps show where Arne Engelsberg may publish in the future.

Co-authorship network of co-authors of Arne Engelsberg

This figure shows the co-authorship network connecting the top 25 collaborators of Arne Engelsberg. A scholar is included among the top collaborators of Arne Engelsberg based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Arne Engelsberg. Arne Engelsberg is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
#WorkIndexed citations
1 0
2 4
3 21
4 5
5 52
6 2
7 1
8 1
9 38
10 34
11 26
12 38
13 57
14
5-aza-2'-deoxycytidine-induced expression of functional cancer testis antigens in human renal cell carcinoma: immunotherapeutic implications.
130
15 58
16
Heterogeneous expression of the tumor-associated antigens RAGE-1, PRAME, and glycoprotein 75 in human renal cell carcinoma: candidates for T-cell-based immunotherapies?
133

About Arne Engelsberg

Arne Engelsberg is a scholar working on Oncology, Immunology and Pulmonary and Respiratory Medicine, having authored 16 papers that have together received 600 indexed citations. Recurring topics across this work include Prostate Cancer Treatment and Research (4 papers), PARP inhibition in cancer therapy (4 papers) and Polyomavirus and related diseases (3 papers). The work is most often cited by research in Immunology (271 citations), Oncology (251 citations) and Cell Biology (70 citations). Arne Engelsberg has collaborated with scholars based in Germany, United States and France. Frequent co-authors include Barbara Seliger, Armin Rehm, Stefan Störkel, C. Huber, Jean Decker, Elena Neumann, E. Jaeger, Ricardo Hermosilla, Bernd Dörken and Eugene Maraskovsky. Their work appears in journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and Cancer Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026